HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 111 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $433,000 | +104.2% | 9,754 | -40.4% | 0.47% | +113.1% |
Q1 2017 | $212,000 | +61.8% | 16,367 | +51.3% | 0.22% | -38.8% |
Q3 2016 | $131,000 | -55.1% | 10,817 | -63.4% | 0.36% | -83.7% |
Q2 2014 | $292,000 | +117.9% | 29,578 | +143.9% | 2.21% | +32.2% |
Q3 2013 | $134,000 | – | 12,125 | – | 1.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRAN CAPITAL MANAGEMENT, L.P. | 1,084,118 | $61,686,285 | 7.80% |
SNYDER CAPITAL MANAGEMENT L P | 3,983,814 | $226,679,017 | 5.12% |
First Light Asset Management, LLC | 923,119 | $52,525,471 | 4.88% |
Redwood Investments, LLC | 441,809 | $25,138,932 | 3.37% |
BERNZOTT CAPITAL ADVISORS | 444,728 | $25,305,023 | 3.27% |
DOHENY ASSET MANAGEMENT /CA | 46,050 | $2,620 | 3.04% |
Crawford Lake Capital Management, LLC | 42,171 | $2,399,530 | 2.75% |
2Xideas AG | 416,586 | $23,703,743 | 2.51% |
Granite Investment Partners, LLC | 902,882 | $51,373,986 | 2.14% |
HighMark Wealth Management LLC | 41,790 | $2,377,851 | 1.79% |